Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Biotech rivals clash as Arrowhead sues Ionis over RNA-based triglyceride therapy Arrowhead sues Ionis over APOC3 patent dispute as plozasiran nears FDA approval. Discover what’s at stake in this RNA-based biotech rivalry. byPallavi MadhirajuSeptember 11, 2025